Fig. 2.
Fig. 2. Appearance of soluble CD23 in the supernatant after lymphocyte exposure to BzATP but not PMA. Lymphocytes were treated with 100 nmol/L PMA (lanes 1 and 2) or 0.2 mmol/L BzATP (lanes 3 and 4) for 30 minutes. CD23 was detected in supernatants (lanes 1 and 3) or cell lysates (lanes 2 and 4) by Western blotting. Lane 5 is a cell lysate of untreated lymphocytes. No bands were detected using an irrelevant control antibody.

Appearance of soluble CD23 in the supernatant after lymphocyte exposure to BzATP but not PMA. Lymphocytes were treated with 100 nmol/L PMA (lanes 1 and 2) or 0.2 mmol/L BzATP (lanes 3 and 4) for 30 minutes. CD23 was detected in supernatants (lanes 1 and 3) or cell lysates (lanes 2 and 4) by Western blotting. Lane 5 is a cell lysate of untreated lymphocytes. No bands were detected using an irrelevant control antibody.

Close Modal

or Create an Account

Close Modal
Close Modal